<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="782" width="593">
	<fontspec id="font0" size="9" family="AdvC2866" color="#231f20"/>
	<fontspec id="font1" size="9" family="AdvTimes" color="#231f20"/>
	<fontspec id="font2" size="9" family="AdvC2867" color="#231f20"/>
	<fontspec id="font3" size="9" family="AdvP4C4E74" color="#231f20"/>
	<fontspec id="font4" size="10" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font5" size="9" family="AdvPS586B" color="#231f20"/>
	<fontspec id="font6" size="6" family="AdvC2866" color="#231f20"/>
	<fontspec id="font7" size="10" family="AdvPSMy-B" color="#231f20"/>
	<fontspec id="font8" size="9" family="AdvPSMP13" color="#231f20"/>
	<fontspec id="font9" size="9" family="AdvPSMy-B" color="#231f20"/>
	<fontspec id="font10" size="9" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font11" size="8" family="AdvPSMy-B" color="#231f20"/>
	<fontspec id="font12" size="8" family="AdvPSMy-BI" color="#231f20"/>
	<fontspec id="font13" size="8" family="AdvP4C4E74" color="#231f20"/>
	<fontspec id="font14" size="7" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font15" size="5" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font16" size="8" family="AdvPSMy-R" color="#231f20"/>
<text top="50" left="45" width="243" height="8" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="text">concentrations of EL was constructed. The concentration of</text>
<text top="61" left="45" width="243" height="8" font="font0" id="p1_t2" reading_order_no="2" segment_no="1" tag_type="text">the plasma samples was determined by comparison to the</text>
<text top="72" left="45" width="243" height="8" font="font0" id="p1_t3" reading_order_no="3" segment_no="1" tag_type="text">standard curve multiplied by the dilution factor. Using this</text>
<text top="83" left="45" width="243" height="8" font="font0" id="p1_t4" reading_order_no="4" segment_no="1" tag_type="text">ELISA, EL mass concentrations were quantiﬁed in plasma</text>
<text top="94" left="45" width="140" height="8" font="font0" id="p1_t5" reading_order_no="5" segment_no="1" tag_type="text">collected in the routine manner (</text>
<text top="93" left="185" width="4" height="8" font="font1" id="p1_t6" reading_order_no="6" segment_no="1" tag_type="text">‘‘</text>
<text top="94" left="189" width="48" height="8" font="font0" id="p1_t7" reading_order_no="7" segment_no="1" tag_type="text">pre-heparin</text>
<text top="93" left="237" width="4" height="8" font="font1" id="p1_t8" reading_order_no="8" segment_no="1" tag_type="text">’’</text>
<text top="94" left="246" width="42" height="8" font="font0" id="p1_t9" reading_order_no="9" segment_no="1" tag_type="text">plasma) in</text>
<text top="105" left="45" width="64" height="8" font="font0" id="p1_t10" reading_order_no="10" segment_no="1" tag_type="text">the full sample (</text>
<text top="105" left="109" width="5" height="8" font="font2" id="p1_t11" reading_order_no="11" segment_no="1" tag_type="text">n</text>
<text top="104" left="115" width="7" height="9" font="font3" id="p1_t12" reading_order_no="12" segment_no="1" tag_type="text">¼</text>
<text top="105" left="123" width="165" height="8" font="font0" id="p1_t13" reading_order_no="13" segment_no="1" tag_type="text">858) as well as in the post-heparin plasma</text>
<text top="116" left="45" width="104" height="8" font="font0" id="p1_t14" reading_order_no="14" segment_no="1" tag_type="text">samples described above (</text>
<text top="116" left="149" width="5" height="8" font="font2" id="p1_t15" reading_order_no="15" segment_no="1" tag_type="text">n</text>
<text top="115" left="156" width="7" height="9" font="font3" id="p1_t16" reading_order_no="16" segment_no="1" tag_type="text">¼</text>
<text top="116" left="165" width="19" height="8" font="font0" id="p1_t17" reading_order_no="17" segment_no="1" tag_type="text">510).</text>
<text top="134" left="45" width="77" height="9" font="font4" id="p1_t18" reading_order_no="18" segment_no="4" tag_type="title">Statistical Analysis</text>
<text top="146" left="54" width="234" height="8" font="font0" id="p1_t19" reading_order_no="19" segment_no="5" tag_type="text">Data are reported as median and interquartile range (IQR)</text>
<text top="158" left="45" width="34" height="8" font="font0" id="p1_t20" reading_order_no="20" segment_no="5" tag_type="text">or mean</text>
<text top="157" left="82" width="7" height="8" font="font5" id="p1_t21" reading_order_no="21" segment_no="5" tag_type="text">6</text>
<text top="158" left="93" width="195" height="8" font="font0" id="p1_t22" reading_order_no="22" segment_no="5" tag_type="text">standard deviation for continuous variables and</text>
<text top="169" left="45" width="243" height="8" font="font0" id="p1_t23" reading_order_no="23" segment_no="5" tag_type="text">as proportions for categorical variables. The distributions of</text>
<text top="180" left="45" width="243" height="8" font="font0" id="p1_t24" reading_order_no="24" segment_no="5" tag_type="text">both pre-heparin and post-heparin EL mass concentrations</text>
<text top="191" left="45" width="243" height="8" font="font0" id="p1_t25" reading_order_no="25" segment_no="5" tag_type="text">were highly skewed rightward, so analyses were performed on</text>
<text top="202" left="45" width="243" height="8" font="font0" id="p1_t26" reading_order_no="26" segment_no="5" tag_type="text">log-transformed data. Variables were determined to be</text>
<text top="213" left="45" width="243" height="8" font="font0" id="p1_t27" reading_order_no="27" segment_no="5" tag_type="text">normally distributed using the Shapiro-Wilk test. Spearman</text>
<text top="224" left="45" width="243" height="8" font="font0" id="p1_t28" reading_order_no="28" segment_no="5" tag_type="text">correlations of EL mass with cardiovascular risk factors and</text>
<text top="235" left="45" width="243" height="8" font="font0" id="p1_t29" reading_order_no="29" segment_no="5" tag_type="text">with concentrations of lipoprotein particles, measured by</text>
<text top="246" left="45" width="243" height="8" font="font0" id="p1_t30" reading_order_no="30" segment_no="5" tag_type="text">NMR, are presented. The association of EL mass with</text>
<text top="257" left="45" width="243" height="8" font="font0" id="p1_t31" reading_order_no="31" segment_no="5" tag_type="text">categorical variables was examined using Kruskal-Wallis rank</text>
<text top="268" left="45" width="243" height="8" font="font0" id="p1_t32" reading_order_no="32" segment_no="5" tag_type="text">test. Data were analyzed in the total group and in men and</text>
<text top="279" left="45" width="243" height="8" font="font0" id="p1_t33" reading_order_no="33" segment_no="5" tag_type="text">women separately, because the distributions of CAC, HDL,</text>
<text top="290" left="45" width="243" height="8" font="font0" id="p1_t34" reading_order_no="34" segment_no="5" tag_type="text">EL, and many risk factors vary with gender [24,25]. Differ-</text>
<text top="302" left="45" width="243" height="8" font="font0" id="p1_t35" reading_order_no="35" segment_no="5" tag_type="text">ences in log-transformed EL mass by gender, and cut-points</text>
<text top="313" left="45" width="243" height="8" font="font0" id="p1_t36" reading_order_no="36" segment_no="5" tag_type="text">in waist circumference and other risk factors were measured</text>
<text top="324" left="45" width="243" height="8" font="font0" id="p1_t37" reading_order_no="37" segment_no="5" tag_type="text">by t-test. Median CAC scores were compared across quartiles</text>
<text top="335" left="45" width="243" height="8" font="font0" id="p1_t38" reading_order_no="38" segment_no="5" tag_type="text">of plasma EL (pre-heparin: 6–268, 268.5–422, 422.5–641, and</text>
<text top="346" left="45" width="243" height="8" font="font0" id="p1_t39" reading_order_no="39" segment_no="5" tag_type="text">641.5–2,043; post-heparin: 102–888, 888.5–1,313, 1,313.5–</text>
<text top="357" left="45" width="243" height="8" font="font0" id="p1_t40" reading_order_no="40" segment_no="5" tag_type="text">1,927, and 1,927.5–7,505) using the Wilcoxon test for trend.</text>
<text top="368" left="45" width="243" height="8" font="font0" id="p1_t41" reading_order_no="41" segment_no="5" tag_type="text">Ordinal logistic regression is a method appropriate for the</text>
<text top="379" left="45" width="243" height="8" font="font0" id="p1_t42" reading_order_no="42" segment_no="5" tag_type="text">analysis of CAC data that has a markedly non-normal</text>
<text top="390" left="45" width="243" height="8" font="font0" id="p1_t43" reading_order_no="43" segment_no="5" tag_type="text">distribution and a signiﬁcant proportion of participants with</text>
<text top="401" left="45" width="243" height="8" font="font0" id="p1_t44" reading_order_no="44" segment_no="5" tag_type="text">no detectable CAC [26]. CAC scores were divided into</text>
<text top="412" left="45" width="243" height="8" font="font0" id="p1_t45" reading_order_no="45" segment_no="5" tag_type="text">ordered outcome categories (0, 1–10, 11–100, 101–400, and</text>
<text top="423" left="45" width="7" height="8" font="font5" id="p1_t46" reading_order_no="46" segment_no="5" tag_type="text">.</text>
<text top="423" left="52" width="236" height="8" font="font0" id="p1_t47" reading_order_no="47" segment_no="5" tag_type="text">400) using published criteria [27] as described [26,28]. The</text>
<text top="435" left="45" width="243" height="8" font="font0" id="p1_t48" reading_order_no="48" segment_no="5" tag_type="text">association of EL mass with CAC was assessed in multivariable</text>
<text top="446" left="45" width="235" height="8" font="font0" id="p1_t49" reading_order_no="49" segment_no="5" tag_type="text">models that also included: (1) gender and age (age and age</text>
<text top="444" left="280" width="3" height="6" font="font6" id="p1_t50" reading_order_no="50" segment_no="5" tag_type="text">2</text>
<text top="446" left="283" width="5" height="8" font="font0" id="p1_t51" reading_order_no="51" segment_no="5" tag_type="text">);</text>
<text top="457" left="45" width="243" height="8" font="font0" id="p1_t52" reading_order_no="52" segment_no="5" tag_type="text">(2) established risk factors, gender, and age; and (3) waist</text>
<text top="468" left="45" width="243" height="8" font="font0" id="p1_t53" reading_order_no="53" segment_no="5" tag_type="text">circumference, medications (including hormone replacement</text>
<text top="479" left="45" width="243" height="8" font="font0" id="p1_t54" reading_order_no="54" segment_no="5" tag_type="text">therapy in women), established risk factors, gender, and age.</text>
<text top="490" left="45" width="243" height="8" font="font0" id="p1_t55" reading_order_no="55" segment_no="5" tag_type="text">Established risk factors included total (or LDL) and HDL</text>
<text top="501" left="45" width="243" height="8" font="font0" id="p1_t56" reading_order_no="56" segment_no="5" tag_type="text">cholesterol, triglycerides, systolic blood pressure, smoking</text>
<text top="512" left="45" width="243" height="8" font="font0" id="p1_t57" reading_order_no="57" segment_no="5" tag_type="text">(current versus never and ex-smokers), race, exercise (none</text>
<text top="523" left="45" width="243" height="8" font="font0" id="p1_t58" reading_order_no="58" segment_no="5" tag_type="text">versus any), fasting glucose, and alcohol intake (drinks per</text>
<text top="534" left="45" width="243" height="8" font="font0" id="p1_t59" reading_order_no="59" segment_no="5" tag_type="text">week). The results of ordinal logistic regression are presented</text>
<text top="545" left="45" width="243" height="8" font="font0" id="p1_t60" reading_order_no="60" segment_no="5" tag_type="text">as the odds ratio (OR) of being in a higher CAC category</text>
<text top="556" left="45" width="243" height="8" font="font0" id="p1_t61" reading_order_no="61" segment_no="5" tag_type="text">comparing the highest quartile of EL mass to the lowest</text>
<text top="567" left="45" width="243" height="8" font="font0" id="p1_t62" reading_order_no="62" segment_no="5" tag_type="text">quartile. The proportional odds assumption of ordinal</text>
<text top="579" left="45" width="243" height="8" font="font0" id="p1_t63" reading_order_no="63" segment_no="5" tag_type="text">regression was satisﬁed for all models [29]. Data analysis was</text>
<text top="590" left="45" width="243" height="8" font="font0" id="p1_t64" reading_order_no="64" segment_no="5" tag_type="text">performed by the authors (KOB, MR, and MW) using Stata 8.1</text>
<text top="601" left="45" width="180" height="8" font="font0" id="p1_t65" reading_order_no="65" segment_no="5" tag_type="text">(Stata, College Station, Texas, United States).</text>
<text top="624" left="45" width="34" height="10" font="font7" id="p1_t66" reading_order_no="66" segment_no="12" tag_type="title">Results</text>
<text top="640" left="45" width="152" height="9" font="font4" id="p1_t67" reading_order_no="67" segment_no="13" tag_type="title">Characteristics of Study Participants</text>
<text top="652" left="54" width="234" height="8" font="font0" id="p1_t68" reading_order_no="68" segment_no="14" tag_type="text">The characteristics of the study participants are summar-</text>
<text top="663" left="45" width="243" height="8" font="font0" id="p1_t69" reading_order_no="69" segment_no="14" tag_type="text">ized in Table 1. Compared to the 2002 CDC report on the</text>
<text top="674" left="45" width="243" height="8" font="font0" id="p1_t70" reading_order_no="70" segment_no="14" tag_type="text">body weight status of US adults [30], there were fewer</text>
<text top="685" left="45" width="243" height="8" font="font0" id="p1_t71" reading_order_no="71" segment_no="14" tag_type="text">individuals of healthy weight and more obese individuals in</text>
<text top="696" left="45" width="243" height="8" font="font0" id="p1_t72" reading_order_no="72" segment_no="14" tag_type="text">our cohort. The lipid proﬁles of our participants were similar</text>
<text top="707" left="45" width="243" height="8" font="font0" id="p1_t73" reading_order_no="73" segment_no="14" tag_type="text">to those reported for 20- to 59-year-old participants in the</text>
<text top="719" left="45" width="239" height="8" font="font0" id="p1_t74" reading_order_no="74" segment_no="14" tag_type="text">National Health and Nutrition Examination Survey III [31].</text>
<text top="281" left="306" width="243" height="9" font="font4" id="p1_t75" reading_order_no="133" segment_no="7" tag_type="title">Distribution of EL Mass Concentrations in Pre-Heparin and</text>
<text top="293" left="306" width="87" height="9" font="font4" id="p1_t76" reading_order_no="134" segment_no="7" tag_type="title">Post-Heparin Plasma</text>
<text top="306" left="315" width="234" height="8" font="font0" id="p1_t77" reading_order_no="135" segment_no="8" tag_type="text">Our previous studies indicated that EL, like HL and LPL</text>
<text top="317" left="306" width="243" height="8" font="font0" id="p1_t78" reading_order_no="136" segment_no="8" tag_type="text">[32], is an avid heparin-binding protein (unpublished data),</text>
<text top="328" left="306" width="243" height="8" font="font0" id="p1_t79" reading_order_no="137" segment_no="8" tag_type="text">and we suspected that it would be released by injection of</text>
<text top="340" left="306" width="243" height="8" font="font0" id="p1_t80" reading_order_no="138" segment_no="8" tag_type="text">heparin in humans. Indeed, a preliminary study in 60</text>
<text top="351" left="306" width="243" height="8" font="font0" id="p1_t81" reading_order_no="139" segment_no="8" tag_type="text">individuals with normal lipid proﬁles indicated an approx-</text>
<text top="362" left="306" width="243" height="8" font="font0" id="p1_t82" reading_order_no="140" segment_no="8" tag_type="text">imately 3- to 4-fold increase in EL mass concentrations from</text>
<text top="373" left="306" width="243" height="8" font="font0" id="p1_t83" reading_order_no="141" segment_no="8" tag_type="text">pre-heparin to post-heparin plasma (unpublished data).</text>
<text top="384" left="306" width="243" height="8" font="font0" id="p1_t84" reading_order_no="142" segment_no="8" tag_type="text">Interestingly, EL mass was abundant in pre-heparin plasma</text>
<text top="395" left="306" width="119" height="8" font="font0" id="p1_t85" reading_order_no="143" segment_no="8" tag_type="text">of the entire SIRCA cohort (</text>
<text top="396" left="425" width="5" height="8" font="font2" id="p1_t86" reading_order_no="144" segment_no="8" tag_type="text">n</text>
<text top="395" left="432" width="7" height="9" font="font3" id="p1_t87" reading_order_no="145" segment_no="8" tag_type="text">¼</text>
<text top="395" left="442" width="52" height="8" font="font0" id="p1_t88" reading_order_no="146" segment_no="8" tag_type="text">858), median</text>
<text top="395" left="497" width="7" height="9" font="font3" id="p1_t89" reading_order_no="147" segment_no="8" tag_type="text">¼</text>
<text top="395" left="506" width="43" height="8" font="font0" id="p1_t90" reading_order_no="148" segment_no="8" tag_type="text">442 (range</text>
<text top="407" left="306" width="243" height="8" font="font0" id="p1_t91" reading_order_no="149" segment_no="8" tag_type="text">324–617) ng/ml. After administration of heparin, median</text>
<text top="418" left="306" width="243" height="8" font="font0" id="p1_t92" reading_order_no="150" segment_no="8" tag_type="text">plasma EL concentrations were approximately 3-fold higher</text>
<text top="429" left="306" width="229" height="8" font="font0" id="p1_t93" reading_order_no="151" segment_no="8" tag_type="text">than in pre-heparin samples, 1,313 (888–1,927) ng/ml (</text>
<text top="429" left="535" width="5" height="8" font="font2" id="p1_t94" reading_order_no="152" segment_no="8" tag_type="text">n</text>
<text top="428" left="543" width="7" height="9" font="font3" id="p1_t95" reading_order_no="153" segment_no="8" tag_type="text">¼</text>
<text top="440" left="306" width="243" height="8" font="font0" id="p1_t96" reading_order_no="154" segment_no="8" tag_type="text">510). There were no signiﬁcant differences in pre-heparin EL</text>
<text top="452" left="306" width="243" height="8" font="font0" id="p1_t97" reading_order_no="155" segment_no="8" tag_type="text">mass concentrations between men and women. While median</text>
<text top="463" left="306" width="243" height="8" font="font0" id="p1_t98" reading_order_no="156" segment_no="8" tag_type="text">post-heparin EL concentrations were 16% lower in women,</text>
<text top="474" left="306" width="243" height="8" font="font0" id="p1_t99" reading_order_no="157" segment_no="8" tag_type="text">1,165 (703–1,705) ng/ml, than men, 1,396 (944–2,031) ng/ml,</text>
<text top="485" left="306" width="243" height="8" font="font0" id="p1_t100" reading_order_no="158" segment_no="8" tag_type="text">this difference could be attributed to greater weight in men.</text>
<text top="496" left="315" width="234" height="8" font="font0" id="p1_t101" reading_order_no="159" segment_no="9" tag_type="text">The correlation between pre-heparin and post-heparin EL</text>
<text top="508" left="306" width="55" height="8" font="font0" id="p1_t102" reading_order_no="160" segment_no="9" tag_type="text">mass was 0.46,</text>
<text top="508" left="364" width="4" height="8" font="font2" id="p1_t103" reading_order_no="161" segment_no="9" tag_type="text">p</text>
<text top="507" left="371" width="7" height="8" font="font5" id="p1_t104" reading_order_no="162" segment_no="9" tag_type="text">,</text>
<text top="508" left="380" width="168" height="8" font="font0" id="p1_t105" reading_order_no="163" segment_no="9" tag_type="text">0.001. Using linear regression, pre-heparin</text>
<text top="519" left="306" width="243" height="8" font="font0" id="p1_t106" reading_order_no="164" segment_no="9" tag_type="text">EL mass accounted for 15% of the variation in post-heparin</text>
<text top="530" left="306" width="243" height="8" font="font0" id="p1_t107" reading_order_no="165" segment_no="9" tag_type="text">EL mass. While including age and gender added less than 1%</text>
<text top="541" left="306" width="243" height="8" font="font0" id="p1_t108" reading_order_no="166" segment_no="9" tag_type="text">each, waist circumference accounted for 5% of the variation</text>
<text top="552" left="306" width="100" height="8" font="font0" id="p1_t109" reading_order_no="167" segment_no="9" tag_type="text">in post-heparin EL mass.</text>
<text top="571" left="306" width="224" height="9" font="font4" id="p1_t110" reading_order_no="168" segment_no="10" tag_type="title">Association of EL Mass Concentrations with Nonlipid</text>
<text top="583" left="306" width="114" height="9" font="font4" id="p1_t111" reading_order_no="169" segment_no="10" tag_type="title">Cardiovascular Risk Factors</text>
<text top="595" left="315" width="234" height="8" font="font0" id="p1_t112" reading_order_no="170" segment_no="11" tag_type="text">Differences in EL mass between groups in the presence and</text>
<text top="606" left="306" width="243" height="8" font="font0" id="p1_t113" reading_order_no="171" segment_no="11" tag_type="text">absence of other risk factors were compared by Kruskal-Wallis</text>
<text top="617" left="306" width="5" height="8" font="font8" id="p1_t114" reading_order_no="172" segment_no="11" tag_type="text">v</text>
<text top="616" left="311" width="3" height="6" font="font6" id="p1_t115" reading_order_no="173" segment_no="11" tag_type="text">2</text>
<text top="618" left="318" width="231" height="8" font="font0" id="p1_t116" reading_order_no="174" segment_no="11" tag_type="text">test. There were signiﬁcant positive associations between</text>
<text top="629" left="306" width="155" height="8" font="font0" id="p1_t117" reading_order_no="175" segment_no="11" tag_type="text">hypertension and both pre-heparin (</text>
<text top="629" left="462" width="4" height="8" font="font2" id="p1_t118" reading_order_no="176" segment_no="11" tag_type="text">p</text>
<text top="628" left="470" width="7" height="9" font="font3" id="p1_t119" reading_order_no="177" segment_no="11" tag_type="text">¼</text>
<text top="629" left="481" width="68" height="8" font="font0" id="p1_t120" reading_order_no="178" segment_no="11" tag_type="text">0.004) and post-</text>
<text top="640" left="306" width="73" height="8" font="font0" id="p1_t121" reading_order_no="179" segment_no="11" tag_type="text">heparin EL mass (</text>
<text top="640" left="379" width="4" height="8" font="font2" id="p1_t122" reading_order_no="180" segment_no="11" tag_type="text">p</text>
<text top="639" left="385" width="7" height="9" font="font3" id="p1_t123" reading_order_no="181" segment_no="11" tag_type="text">¼</text>
<text top="640" left="395" width="154" height="8" font="font0" id="p1_t124" reading_order_no="182" segment_no="11" tag_type="text">0.003). There were signiﬁcant negative</text>
<text top="651" left="306" width="243" height="8" font="font0" id="p1_t125" reading_order_no="183" segment_no="11" tag_type="text">associations between exercise and EL mass in both pre-</text>
<text top="662" left="306" width="39" height="8" font="font0" id="p1_t126" reading_order_no="184" segment_no="11" tag_type="text">heparin (</text>
<text top="663" left="345" width="4" height="8" font="font2" id="p1_t127" reading_order_no="185" segment_no="11" tag_type="text">p</text>
<text top="662" left="354" width="7" height="8" font="font5" id="p1_t128" reading_order_no="186" segment_no="11" tag_type="text">,</text>
<text top="662" left="366" width="106" height="8" font="font0" id="p1_t129" reading_order_no="187" segment_no="11" tag_type="text">0.001) and post-heparin (</text>
<text top="663" left="472" width="4" height="8" font="font2" id="p1_t130" reading_order_no="188" segment_no="11" tag_type="text">p</text>
<text top="662" left="480" width="7" height="9" font="font3" id="p1_t131" reading_order_no="189" segment_no="11" tag_type="text">¼</text>
<text top="662" left="491" width="58" height="8" font="font0" id="p1_t132" reading_order_no="190" segment_no="11" tag_type="text">0.015) plasma.</text>
<text top="674" left="306" width="231" height="8" font="font0" id="p1_t133" reading_order_no="191" segment_no="11" tag_type="text">Smoking was associated with higher post-heparin EL mass (</text>
<text top="674" left="537" width="4" height="8" font="font2" id="p1_t134" reading_order_no="192" segment_no="11" tag_type="text">p</text>
<text top="673" left="543" width="7" height="9" font="font3" id="p1_t135" reading_order_no="193" segment_no="11" tag_type="text">¼</text>
<text top="685" left="306" width="25" height="8" font="font0" id="p1_t136" reading_order_no="194" segment_no="11" tag_type="text">0.005).</text>
<text top="696" left="315" width="234" height="8" font="font0" id="p1_t137" reading_order_no="195" segment_no="15" tag_type="text">Correlations of plasma EL mass with age, body mass index</text>
<text top="707" left="306" width="243" height="8" font="font0" id="p1_t138" reading_order_no="196" segment_no="15" tag_type="text">(BMI), waist circumference, blood pressure, fasting glucose,</text>
<text top="719" left="306" width="243" height="8" font="font0" id="p1_t139" reading_order_no="197" segment_no="15" tag_type="text">and the homeostasis model assessment (HOMA) index, a</text>
<text top="60" left="306" width="32" height="8" font="font9" id="p1_t140" reading_order_no="75" segment_no="2" tag_type="title">Table 1.</text>
<text top="60" left="341" width="204" height="8" font="font10" id="p1_t141" reading_order_no="76" segment_no="2" tag_type="title">Clinical and Biochemical Characteristics of the Cohort</text>
<text top="83" left="306" width="49" height="7" font="font11" id="p1_t142" reading_order_no="77" segment_no="3" tag_type="table">Characteristic</text>
<text top="83" left="405" width="21" height="7" font="font11" id="p1_t143" reading_order_no="78" segment_no="3" tag_type="table">Men (</text>
<text top="83" left="426" width="4" height="7" font="font12" id="p1_t144" reading_order_no="79" segment_no="3" tag_type="table">n</text>
<text top="82" left="433" width="6" height="8" font="font13" id="p1_t145" reading_order_no="80" segment_no="3" tag_type="table">¼</text>
<text top="83" left="442" width="16" height="7" font="font11" id="p1_t146" reading_order_no="81" segment_no="3" tag_type="table">466)</text>
<text top="83" left="485" width="32" height="7" font="font11" id="p1_t147" reading_order_no="82" segment_no="3" tag_type="table">Women (</text>
<text top="83" left="517" width="4" height="7" font="font12" id="p1_t148" reading_order_no="83" segment_no="3" tag_type="table">n</text>
<text top="82" left="525" width="6" height="8" font="font13" id="p1_t149" reading_order_no="84" segment_no="3" tag_type="table">¼</text>
<text top="83" left="533" width="16" height="7" font="font11" id="p1_t150" reading_order_no="85" segment_no="3" tag_type="table">392)</text>
<text top="97" left="405" width="47" height="7" font="font11" id="p1_t151" reading_order_no="86" segment_no="3" tag_type="table">Median (IQR)</text>
<text top="97" left="485" width="47" height="7" font="font11" id="p1_t152" reading_order_no="87" segment_no="3" tag_type="table">Median (IQR)</text>
<text top="118" left="306" width="12" height="6" font="font14" id="p1_t153" reading_order_no="88" segment_no="3" tag_type="table">Age</text>
<text top="118" left="412" width="31" height="6" font="font14" id="p1_t154" reading_order_no="89" segment_no="3" tag_type="table">47 (41–52)</text>
<text top="118" left="492" width="31" height="6" font="font14" id="p1_t155" reading_order_no="90" segment_no="3" tag_type="table">51 (45–57)</text>
<text top="127" left="306" width="65" height="6" font="font14" id="p1_t156" reading_order_no="91" segment_no="3" tag_type="table">Cigarette smokers (%)</text>
<text top="127" left="412" width="12" height="6" font="font14" id="p1_t157" reading_order_no="92" segment_no="3" tag_type="table">10.8</text>
<text top="127" left="492" width="12" height="6" font="font14" id="p1_t158" reading_order_no="93" segment_no="3" tag_type="table">12.9</text>
<text top="136" left="306" width="69" height="6" font="font14" id="p1_t159" reading_order_no="94" segment_no="3" tag_type="table">Blood pressure, systolic</text>
<text top="136" left="409" width="42" height="6" font="font14" id="p1_t160" reading_order_no="95" segment_no="3" tag_type="table">129 (120–136)</text>
<text top="136" left="488" width="42" height="6" font="font14" id="p1_t161" reading_order_no="96" segment_no="3" tag_type="table">125 (111–135)</text>
<text top="145" left="306" width="72" height="6" font="font14" id="p1_t162" reading_order_no="97" segment_no="3" tag_type="table">Blood pressure, diastolic</text>
<text top="145" left="412" width="31" height="6" font="font14" id="p1_t163" reading_order_no="98" segment_no="3" tag_type="table">79 (74–85)</text>
<text top="145" left="492" width="31" height="6" font="font14" id="p1_t164" reading_order_no="99" segment_no="3" tag_type="table">75 (68–82)</text>
<text top="154" left="306" width="31" height="6" font="font14" id="p1_t165" reading_order_no="100" segment_no="3" tag_type="table">BMI (kg/m</text>
<text top="153" left="337" width="3" height="4" font="font15" id="p1_t166" reading_order_no="101" segment_no="3" tag_type="table">2</text>
<text top="154" left="339" width="2" height="6" font="font14" id="p1_t167" reading_order_no="102" segment_no="3" tag_type="table">)</text>
<text top="154" left="412" width="46" height="6" font="font14" id="p1_t168" reading_order_no="103" segment_no="3" tag_type="table">27.9 (25.6–30.4)</text>
<text top="154" left="492" width="46" height="6" font="font14" id="p1_t169" reading_order_no="104" segment_no="3" tag_type="table">26.4 (23.1–30.9)</text>
<text top="163" left="306" width="60" height="6" font="font14" id="p1_t170" reading_order_no="105" segment_no="3" tag_type="table">Waist circumference</text>
<text top="163" left="412" width="36" height="6" font="font14" id="p1_t171" reading_order_no="106" segment_no="3" tag_type="table">37.5 (35–41)</text>
<text top="163" left="492" width="31" height="6" font="font14" id="p1_t172" reading_order_no="107" segment_no="3" tag_type="table">32 (29–36)</text>
<text top="172" left="306" width="73" height="6" font="font14" id="p1_t173" reading_order_no="108" segment_no="3" tag_type="table">Total cholesterol (mg/dl)</text>
<text top="172" left="409" width="42" height="6" font="font14" id="p1_t174" reading_order_no="109" segment_no="3" tag_type="table">205 (178–226)</text>
<text top="172" left="488" width="42" height="6" font="font14" id="p1_t175" reading_order_no="110" segment_no="3" tag_type="table">209 (188–238)</text>
<text top="181" left="306" width="72" height="6" font="font14" id="p1_t176" reading_order_no="111" segment_no="3" tag_type="table">LDL-cholesterol (mg/dl )</text>
<text top="181" left="409" width="42" height="6" font="font14" id="p1_t177" reading_order_no="112" segment_no="3" tag_type="table">128 (109–150)</text>
<text top="181" left="488" width="42" height="6" font="font14" id="p1_t178" reading_order_no="113" segment_no="3" tag_type="table">123 (102–146)</text>
<text top="190" left="306" width="71" height="6" font="font14" id="p1_t179" reading_order_no="114" segment_no="3" tag_type="table">HDL-cholesterol (mg/dl)</text>
<text top="190" left="412" width="31" height="6" font="font14" id="p1_t180" reading_order_no="115" segment_no="3" tag_type="table">44 (38–50)</text>
<text top="190" left="492" width="31" height="6" font="font14" id="p1_t181" reading_order_no="116" segment_no="3" tag_type="table">61 (46–70)</text>
<text top="199" left="306" width="65" height="6" font="font14" id="p1_t182" reading_order_no="117" segment_no="3" tag_type="table">Triglycerides ( mg/dl )</text>
<text top="199" left="409" width="38" height="6" font="font14" id="p1_t183" reading_order_no="118" segment_no="3" tag_type="table">129 (92–176)</text>
<text top="199" left="488" width="38" height="6" font="font14" id="p1_t184" reading_order_no="119" segment_no="3" tag_type="table">122 (82–156)</text>
<text top="208" left="306" width="44" height="6" font="font14" id="p1_t185" reading_order_no="120" segment_no="3" tag_type="table">ApoA-l (mg/dl)</text>
<text top="208" left="409" width="47" height="6" font="font14" id="p1_t186" reading_order_no="121" segment_no="3" tag_type="table">116 (102–131.5)</text>
<text top="208" left="488" width="42" height="6" font="font14" id="p1_t187" reading_order_no="122" segment_no="3" tag_type="table">145 (125–164)</text>
<text top="217" left="306" width="40" height="6" font="font14" id="p1_t188" reading_order_no="123" segment_no="3" tag_type="table">ApoB (mg/dl)</text>
<text top="217" left="412" width="40" height="6" font="font14" id="p1_t189" reading_order_no="124" segment_no="3" tag_type="table">99 (86–114.5)</text>
<text top="217" left="492" width="35" height="6" font="font14" id="p1_t190" reading_order_no="125" segment_no="3" tag_type="table">98 (82–113)</text>
<text top="226" left="306" width="67" height="6" font="font14" id="p1_t191" reading_order_no="126" segment_no="3" tag_type="table">Pre-heparin EL (ng/ml)</text>
<text top="226" left="409" width="42" height="6" font="font14" id="p1_t192" reading_order_no="127" segment_no="3" tag_type="table">420 (323–565)</text>
<text top="226" left="488" width="42" height="6" font="font14" id="p1_t193" reading_order_no="128" segment_no="3" tag_type="table">472 (314–663)</text>
<text top="235" left="306" width="70" height="6" font="font14" id="p1_t194" reading_order_no="129" segment_no="3" tag_type="table">Post-heparin EL (ng/ml)</text>
<text top="235" left="405" width="50" height="6" font="font14" id="p1_t195" reading_order_no="130" segment_no="3" tag_type="table">1396 (944–2,031)</text>
<text top="235" left="485" width="50" height="6" font="font14" id="p1_t196" reading_order_no="131" segment_no="3" tag_type="table">1165 (730–1,705)</text>
<text top="260" left="306" width="86" height="5" font="font15" id="p1_t197" reading_order_no="132" segment_no="6" tag_type="text">DOI: 10.1371/journal.pmed.0030022.t001</text>
<text top="742" left="69" width="133" height="7" font="font16" id="p1_t198" reading_order_no="198" segment_no="16" tag_type="text">PLoS Medicine | www.plosmedicine.org</text>
<text top="742" left="411" width="138" height="7" font="font16" id="p1_t199" reading_order_no="200" segment_no="17" tag_type="text">February 2006 | Volume 3 | Issue 2 | e22</text>
<text top="742" left="289" width="16" height="7" font="font16" id="p1_t200" reading_order_no="199" segment_no="18" tag_type="text">0247</text>
<text top="26" left="454" width="95" height="7" font="font16" id="p1_t201" reading_order_no="0" segment_no="0" tag_type="title">EL and Metabolic Syndrome</text>
</page>
</pdf2xml>
